Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Robyn L Schenk

1PUBLICATIONS

9CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Nov 25, 2025

SOS1 inhibition suppresses the emergence of osimertinib resistance to generate a durable response in <i>EGFR</i>-mutant lung cancer.

Brianna R Daley, Patricia L Theard, Jacob M Hughes

Pageof 1

Frequent Collaborators

1 joint publications

Brianna R Daley

1 joint publications

Patricia L Theard

1 joint publications

Jacob M Hughes

1 joint publications

Bridget A Finniff

1 joint publications

Marco H Hofmann

1 joint publications

Kaja Kostyrko

1 joint publications

Heidi M Vieira

1 joint publications

James W Askew

1 joint publications

Robert L Kortum

Frequent Collaborators

1 joint publications

Brianna R Daley

1 joint publications

Patricia L Theard

1 joint publications

Jacob M Hughes

1 joint publications

Bridget A Finniff

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

See more related videos

Top Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on : Nov 22, 2021

See more related videos